reference/12080588

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/12080588

Outgoing Links

Predicate	Object
contentType	Journal Article\|Practice Guideline\|Research Support, N.I.H., Extramural
endingPage	548
issn	1532-6535 0009-9236
issueIdentifier	5
pageRange	542-548
publicationName	Clinical pharmacology and therapeutics
startingPage	542
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_77e2488754b2b37f99f84e3d30d28ece http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a1ebfe17b0713ecaf89801f0370c078d
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_abecbe7e272ad4f2a397d697b7eaf452 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_b4a5df21114b975ac98820c0f3343cdf http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_a4417c1ff2c375e84ed5aeb4741918f2 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_a4e3ebad70d896b7e2b67fc566789b49 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_28a1f473d89da0c507e9950aaaeb747c http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_db0d7dda215bc9927693fa1fc9bb7621 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_998eaafd757dbf89cbd141c55ee1a070 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_a31e0015f3389413b018a2d500973455
bibliographicCitation	Caudle KE, Rettie AE, Whirl-Carrillo M, Smith LH, Mintzer S, Lee MT, Klein TE, Callaghan JT; Clinical Pharmacogenetics Implementation Consortium. Clinical pharmacogenetics implementation consortium guidelines for CYP2C9 and HLA-B genotypes and phenytoin dosing. Clin Pharmacol Ther. 2014 Nov;96(5):542–8. PMID: 25099164; PMCID: PMC4206662.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_055797eb63f3b3422c18e07a1e1a2f56 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9c037c7941b47f4fc7571498b7adf671 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_497e703b1079f511688e29297e266fc3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f7f76164ab4d8b024dde5fb538b6f5ba http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_768fabc703951251862ab00037658391 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_54a583a3991826589b7d623b28cb4c0e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c43957352acb1957cf2e5b08d782e34d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fb257b4fc64407bc0fd05858a0fb7e26
date	2014-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1038/clpt.2014.159 https://pubmed.ncbi.nlm.nih.gov/25099164 https://pubmed.ncbi.nlm.nih.gov/PMC4206662
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3058 https://portal.issn.org/resource/ISSN/1532-6535 https://portal.issn.org/resource/ISSN/0009-9236
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://scigraph.springernature.com/ https://www.crossref.org/
title	Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and HLA-B Genotypes and Phenytoin Dosing
discusses	http://id.nlm.nih.gov/mesh/M0590597 http://id.nlm.nih.gov/mesh/M0023414 http://id.nlm.nih.gov/mesh/M0016580 http://id.nlm.nih.gov/mesh/M0001382
hasSubjectTerm	http://purl.org/au-research/vocabulary/anzsrc-for/2008/11 http://purl.org/au-research/vocabulary/anzsrc-for/2008/1115
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_1.14.14.1 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c25c5bef0fa0efbec10a882f149a99d6 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_61f7a5e5e1b7c9be084045f167e8a8b7 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_eb6f5112a467cf2f956b874bbf443d46 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9301 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1775

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID53787728 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1559 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3106

Total number of triples: 54.